 |  | Israel's Teva seeks partners to fund some drug development |  | JERUSALEM (Reuters) - Teva Pharmaceutical Industries said on Wednesday it was looking into a series of partnerships to fund some projects in its drug development pipeline, as the drugmaker seeks to pay down more than $5 billion of debt this year. |
|  |
|  |  | |  |  | Related Video |
|  | |  | |  |  |  | Related News |
|  | |  | |  |  |  |  |  | Make sense of the market with highlights of valuable financial information and reports along with compelling investment insights. Register Today |  |
|  |  |  | Get a jump on the day with our early morning summary of key news developments for the US markets, as well as global market news. Register Today |  |
|  | » » MORE NEWSLETTERS |  |
|